Mohammed, O.A.; Abdel-Reheim, M.A.; Saleh, L.A.; Alamri, M.M.S.; Alfaifi, J.; Adam, M.I.E.; Farrag, A.A.; AlQahtani, A.A.J.; BinAfif, W.F.; Hashish, A.A.;
et al. Correction: Mohammed et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals 2023, 16, 1123. Pharmaceuticals 2025, 18, 1011.
https://doi.org/10.3390/ph18071011
AMA Style
Mohammed OA, Abdel-Reheim MA, Saleh LA, Alamri MMS, Alfaifi J, Adam MIE, Farrag AA, AlQahtani AAJ, BinAfif WF, Hashish AA,
et al. Correction: Mohammed et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals 2023, 16, 1123. Pharmaceuticals. 2025; 18(7):1011.
https://doi.org/10.3390/ph18071011
Chicago/Turabian Style
Mohammed, Osama A., Mustafa Ahmed Abdel-Reheim, Lobna A. Saleh, Mohannad Mohammad S. Alamri, Jaber Alfaifi, Masoud I. E. Adam, Alshaimaa A. Farrag, AbdulElah Al Jarallah AlQahtani, Waad Fuad BinAfif, Abdullah A. Hashish,
and et al. 2025. "Correction: Mohammed et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals 2023, 16, 1123" Pharmaceuticals 18, no. 7: 1011.
https://doi.org/10.3390/ph18071011
APA Style
Mohammed, O. A., Abdel-Reheim, M. A., Saleh, L. A., Alamri, M. M. S., Alfaifi, J., Adam, M. I. E., Farrag, A. A., AlQahtani, A. A. J., BinAfif, W. F., Hashish, A. A., Abdel-Ghany, S., Elmorsy, E. A., El-wakeel, H. S., Doghish, A. S., Hamad, R. S., & Saber, S.
(2025). Correction: Mohammed et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals 2023, 16, 1123. Pharmaceuticals, 18(7), 1011.
https://doi.org/10.3390/ph18071011
